BR112014032017A2 - dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida - Google Patents

dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida

Info

Publication number
BR112014032017A2
BR112014032017A2 BR112014032017A BR112014032017A BR112014032017A2 BR 112014032017 A2 BR112014032017 A2 BR 112014032017A2 BR 112014032017 A BR112014032017 A BR 112014032017A BR 112014032017 A BR112014032017 A BR 112014032017A BR 112014032017 A2 BR112014032017 A2 BR 112014032017A2
Authority
BR
Brazil
Prior art keywords
solid dispersion
producing
extruded
substitution
dispersion
Prior art date
Application number
BR112014032017A
Other languages
English (en)
Inventor
P O'donnell Kevin
j hall Mark
L Rose Maureen
S Grasman Nicholas
J Guillaudeu Steven
L Rogers True
Shrestha Uma
J Spaulding Wesley
W Porter William
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Publication of BR112014032017A2 publication Critical patent/BR112014032017A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Abstract

resumo “dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida” uma dispersão sólida compreendendo pelo menos um ingrediente ativo em pelo menos uma hidroxialquil metil celulose tendo um ds de 1,0 a 2,7 e uma ms de 0,40 a 1,30, sendo que ds é o grau de substituição de grupos metoxila e ms é a substituição molar de grupos hidroxialcoxila, pode ser produzida por extrusão ou por secagem por aspersão. 1/1
BR112014032017A 2012-07-17 2013-07-12 dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida BR112014032017A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261672409P 2012-07-17 2012-07-17
PCT/US2013/050213 WO2014014752A1 (en) 2012-07-17 2013-07-12 Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose

Publications (1)

Publication Number Publication Date
BR112014032017A2 true BR112014032017A2 (pt) 2017-06-27

Family

ID=48857004

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014032017A BR112014032017A2 (pt) 2012-07-17 2013-07-12 dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida

Country Status (8)

Country Link
US (1) US9962446B2 (pt)
EP (1) EP2874607B1 (pt)
JP (1) JP6235584B2 (pt)
KR (1) KR102160903B1 (pt)
CN (1) CN104602673B (pt)
BR (1) BR112014032017A2 (pt)
PT (1) PT2874607T (pt)
WO (1) WO2014014752A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358133B (zh) * 2013-07-17 2017-04-26 陶氏环球技术有限责任公司 用于施加到粘膜的包含羟烷基甲基纤维素的组合物
CA2936357C (en) * 2014-01-16 2022-04-26 Dow Global Technologies Llc Support materials for 3d printing
EP3307839B1 (en) * 2015-06-09 2019-02-27 Dow Global Technologies LLC Support materials for 3d printing
EP3328930B1 (en) * 2015-07-27 2019-05-29 Dow Global Technologies LLC Method to additive manufacture biocompatible material and articles made by the method
CN106556567A (zh) * 2016-10-01 2017-04-05 德州学院 一种羟丙基甲基纤维素羟丙基取代度的测试方法
JP2023504289A (ja) 2019-12-09 2023-02-02 ニュートリション アンド バイオサイエンシス ユーエスエー １，エルエルシー 高度置換ヒドロキシプロピルメチルセルロース及び糖アルコールを含む組成物
CN114867800A (zh) * 2019-12-30 2022-08-05 陶氏环球技术有限责任公司 水性组合物及其制备方法
WO2023006424A1 (en) 2021-07-28 2023-02-02 Nutrition & Biosciences Usa 1, Llc Hpmc composition for providing a heat-sealable coating on paper and board

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4614545A (en) 1985-08-15 1986-09-30 The Dow Chemical Company Hydroxypropyl methyl cellulose thickening agents for organic liquids
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US5721221A (en) 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
JPH06239764A (ja) * 1993-02-17 1994-08-30 Yoshiaki Kawashima 錠剤用基剤組成物およびその製造方法
AU722101B2 (en) 1996-05-20 2000-07-20 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
ES2287971T3 (es) * 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
KR20010097244A (ko) 2000-04-21 2001-11-08 유충식 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
ES2289130T3 (es) * 2001-09-04 2008-02-01 Dow Global Technologies Inc. Procedimiento para revestir particulas solidas.
KR20050044334A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 시스-융합된3,3ａ,8,12ｂ-테트라하이드로-2Ｈ-디벤조[3,4:6,7]사이클로헵타[1,2-ｂ]푸란 유도체의 제조
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
EP1753402B1 (en) 2004-05-28 2008-10-01 Pfizer Products Incorporated Pharmaceutical compositions with enhanced performance comprising a hpmca polymer
JP4887727B2 (ja) * 2005-10-20 2012-02-29 ソニー株式会社 画像信号処理装置、カメラシステム、および画像信号処理方法
US8030359B2 (en) * 2006-02-09 2011-10-04 Merck Sharp & Dohme Corp. Polymer formulations of CETP inhibitors
WO2008047201A2 (en) 2006-10-17 2008-04-24 Pfizer Products Inc. Solid dispersion comprising a poorly water soluble drug
KR101498639B1 (ko) * 2008-06-26 2015-03-11 에스에스 세야쿠 가부시키 가이샤 필름 코팅용 조성물
CN104364329B (zh) * 2012-04-11 2016-08-17 陶氏环球技术有限责任公司 包含有机稀释剂和纤维素醚的组合物

Also Published As

Publication number Publication date
PT2874607T (pt) 2017-08-14
KR102160903B1 (ko) 2020-10-05
CN104602673B (zh) 2017-11-24
US9962446B2 (en) 2018-05-08
EP2874607B1 (en) 2017-05-31
JP2015522613A (ja) 2015-08-06
CN104602673A (zh) 2015-05-06
US20150140091A1 (en) 2015-05-21
KR20150031299A (ko) 2015-03-23
WO2014014752A1 (en) 2014-01-23
EP2874607A1 (en) 2015-05-27
JP6235584B2 (ja) 2017-11-22

Similar Documents

Publication Publication Date Title
BR112014032017A2 (pt) dispersão sólida, dispersão sólida extrudada e processo para produzir uma dispersão sólida
BR112014032147A2 (pt) processo para a preparação de um derivado de polissacarídeo, e, derivado de polissacarídeo
WO2013142471A3 (en) Cross linked silicone copolmyer networks in a thickened aqueous phase
BR112016007044A2 (pt) método de preparação de amido pré-gelatinizado, parcialmente hidrolisado e métodos e produtos relacionados
BR112012033637A8 (pt) Macarrão seco e processo para produzir o mesmo
BR112016027830A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos de produção de composição de fibra, de elaboração de composição de carboidrato misturada, de redução do índice glicêmico e de inibição da elevação do nível de açúcar no sangue, composição cosmética, uso da composição de fibra e composição
BR112016024698A2 (pt) filamentos e estruturas fibrosas que empregam os mesmos
BR112015021994A8 (pt) produto de papel, composição adequada para sua fabricação e processo de preparação do mesmo
BR112013028832A2 (pt) composição alimentícia, uso de éter de celulose e método para melhorar uma ou mais das propriedades de uma composição alimentícia
BR112015020000A2 (pt) fibra kraft quimicamente modificada e métodos de fabricação da mesma
BR112016013194A2 (pt) Composições de higiene oral compreendendo carbonato de cálcio e sílica
BR112014019761A8 (pt) Composição
BR112015010678A2 (pt) compostos de junta ready-mix usando carboximetilcelulose substituída não uniformemente
BR112015019575A2 (pt) polissacarídeo solúvel em água livre de amido, alimento, ingrediente de alimento, ou suplemento alimentício e método para melhorar a palatabilidade de um polissacarídeo solúvel em água livre de amido
BR112014003139A2 (pt) musgo de turfa umectável resistente à lixiviação, método de preparação, e método de uso
BR112019000110A2 (pt) método para fabricação de produto intermediário para conversão para celulose microfibrilada
BR112015023728A2 (pt) compósito, processo para preparação de um compósito, produto de consumo, uso de um compósito, e, método para preparação de um produto
BR112015028325A2 (pt) processo para fabricar lítio carboximetil celulose
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
BR112015004979A2 (pt) processo para melhorar as propriedades reológicas de uma dispersão aquosa
BR112015016090A2 (pt) nó de uma rede sem fio e método para controlar um nó de uma rede sem fio
BR112014004362A2 (pt) composição de revestimento, processo para preparar uma composição de revestimento, forma de dosagem e processo para revestir uma forma de dosagem
BR112015015841A2 (pt) argamassa seca que pode ser definida por um processo de teste especial e objetivos de invenção relacionados
BR112016006624A2 (pt) composição para cuidado oral
BR112018072920A2 (pt) partículas de catalisador sólido, processo para preparação das partículas de catalisador sólido, uso das partículas de catalisador sólido, e, poliolefina.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: THE DOW CHEMICAL COMPANY (US)

B25A Requested transfer of rights approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, INC. (US)

B25D Requested change of name of applicant approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, LLC (US)

B25A Requested transfer of rights approved

Owner name: NUTRITION AND BIOSCIENCES USA 1, LLC (US)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time